Gentisic acid, an aspirin metabolite, inhibits oxidation of low-density lipoprotein and the formation of cholesterol ester hydroperoxides in human plasma

European Journal of Pharmacology

Volumn 513, Issue 3, 2005, Pages 173-179

  Ashidate, Keiko ^a,b   Kawamura, Mitsunobu ^b   Mimura, Daigo ^c   Tohda, Hisako ^b   Miyazaki, Shigeru ^b   Teramoto, Tamio ^c   Yamamoto, Yorihiro ^d   Hirata, Yukio ^e  

^a Kudanzaka Hospital   (Japan)

^b TOKYO TEISHIN HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Antioxidant; Aspirin; Gentisic acid; LDL oxidation

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; CHOLESTEROL ESTER; DRUG METABOLITE; GENTISIC ACID; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; UBIDECARENONE;

ARTICLE; CHELATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; OXIDATION; PLASMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 18144375962     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.03.012     Document Type: Article

References (26)

1. E.H. Awtry, and J. Loscalzo Aspirin Circulation 101 2000 1206 1218
2. M.S. Blois Antioxidant determinations by the use of a stable free radical Nature 181 1958 1199 1200
3. B.H. Chung, T. Wilkinson, J.C. Geer, and P. Segrest Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor J. Lipid Res. 21 1980 284 291
4. W.B. Davis, B.S. Mohammed, D.C. Mays, Z.W. She, J.R. Mohammed, R.M. Husney, and A.L. Sagone Hydroxylation of salicylate by activated neutrophils Biochem. Pharmacol. 38 1989 4013 4019
5. H. Esterbauer, G. Striegl, H. Puhl, and M. Rotheneder Continuous monitoring of in vitro oxidation of human low density lipoprotein Free Radic. Res. Commun. 6 1989 67 75
6. M. Exner, M. Hermann, R. Hofbauer, S. Kapiotis, W. Speiser, I. Held, C. Seelos, and B.M.K. Gmeiner The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein FEBS Lett. 470 2000 47 50
7. B. Frei, R. Stocker, and B.N. Ames Antioxidant defenses and lipid peroxidation in human blood plasma Proc. Natl. Acad. Sci. U. S. A. 85 1988 9748 9752
8. A. Graham, J.L. Wood, V.J. O'Leary, and D. Stone Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism Free Radic. Res. 21 1994 295 308
9. M. Grootveld, and B. Halliwell Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo Biochem. J. 237 1986 499 504
10. J.M.C. Gutteridge Lipid peroxidation and antioxidants as biomarkers of tissue damage Clin. Chem. 41 1994 1819 1828
11. J.W. Heinecke Oxidants and antioxidants in pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis Atherosclerosis 141 1998 1 15
12. M. Hermann, S. Kapiotis, R. Hofbauer, M. Exner, C. Seelos, I. Held, and B. Gmeiner Salicylate inhibits LDL oxidation initiated by superoxide/nitric oxide radicals FEBS Lett. 445 1999 212 214
13. 2 synthesis in murine macrophages Biochem. Biophys. Res. Commun. 274 2000 197 202
14. J.V. Hunt, C.C.T. Smith, and S.P. Wolff Autoxidative glycosilation and possible involvement of peroxides and free radicals in LDL modification by glucose Diabetes 39 1990 1420 1424
15. M. Kawamura, J.W. Heinecke, and A. Chait Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway J. Clin. Invest. 94 1994 771 778
16. K. Kondo, A. Matsumoto, H. Kurata, H. Tanahashi, H. Koda, T. Amachi, and H. Itakura Inhibition of oxidation of low-density lipoprotein with red wine Lancet 344 1994 1152
17. C. Naito, M. Kawamura, and Y. Yamamoto Lipid peroxides as the initiating factor of atherosclerosis Ann. N.Y. Acad. Sci. 676 1993 27 45
18. C.J. Needs, and P.M. Brooks Clinical pharmacokinetics of the salicylates Clin. Pharmacokinet. 10 1985 164 177
19. A.L. Sagone, and R.M. Husney Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems J. Immunol. 138 1987 2177 2183
20. J. Shen, S. Wanwimolruk, R.D. Purves, E.G. McQueen, and M.S. Roberts Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose J. Pharmacokinet. Biopharm. 19 1991 575 595
21. D. Steinberg Low density lipoprotein oxidation and its pathobiological significance J. Biol. Chem. 272 1997 20963 20966
22. D. Steinberg, S. Parthasarathy, T. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity N. Engl. J. Med. 320 1989 915 924
23. Y. Yamamoto, and B.N. Ames Detection of lipid hydroperoxides and hydrogen peroxide at picomole levels by an HPLC and isoluminol chemiluminescence assay Free Radic. Biol Med. 3 1987 359 361
24. Y. Yamamoto, and E. Niki Presence of cholesteryl ester hydroperoxide in human blood plasma Biochem. Biophys. Res. Commun. 165 1989 988 993
25. S. Yamashita, and Y. Yamamoto Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress Anal. Biochem. 250 1997 66 73
26. Forth, W., Henschler, D., Rummel, W., 1987. Allgemeine und spezielle pharmakologie und toxikologie. Wien, Zurich: Wissenschaftsverlag, Mannheim.